Lupin

Lupin

LUPIN

option chainOption chain
 ₹ 1,608.55
 ₹ 24.60
1.55%

Lupin  
Market Sentiment

TimelineReturnsVolume
Daily--
Weekly-2.79%94,36,204
Monthly0.25%2,20,19,919

Lupin  
Performance

TimelineDailyWeeklyMonthly
LUPIN--2.79%0.25%
Index--1.46%-2.67%
Peer Avg.--3.09%-0.56%
*Avg of index constituents

Lupin  
Fundamentals

TimelinePEPBEV/EBIDTAROEROCEDiv. Yield
LUPIN37.442.3626.89-6.42-3.790.53
Index36.206.7717.2517.8919.691.20
Peer Avg.40.044.9612.3514.7418.510.87
*Avg of index constituents

Lupin  
Key Metrics

MetricsSales GrowthProfit GrowthROEROCE
FY '21-227.33%-169.04%-6.42-3.79
FY '20-21-4.83%310.56%8.269.45
FY '19-20-1.20%-98.73%1.076.20

Lupin  
Shareholding Pattern

PromotersFIIDIIPublicOthers
Promoters : 46.78%
FII : 14.65%
DII : 27.2%
Public : 11.37%
Others : 0%

Lupin  
Profit & Loss

MetricsSalesExpenditureEBITDAPAT
FY '21-2214,088.5813,878.47427.52-849.21
FY '20-2113,109.4410,803.982,438.161,242.61
FY '19-2013,931.1111,740.132,670.45226.91
All values are in crores

Lupin  
Peer Comparison

MetricsSalesExpenditureEBITDAPAT
LUPIN14,088.5813,878.47427.52-849.21
STARHEALTH000-1,040.67
GODREJPROP1,649.161,535.04923.77532.63
All values are in crores

Lupin  
Similar Stocks

Cipla

Cipla

CIPLA

 ₹ 1,339.55
- ₹ 19.25
-1.41%
Dr. Reddy's Laboratories

Dr. Reddy's Laboratories

DRREDDY

 ₹ 5,921.00
 ₹ 43.65
0.74%
Torrent Pharmaceuticals

Torrent Pharmaceuticals

TORNTPHARM

 ₹ 2,599.90
 ₹ 75.55
2.99%
Glaxosmithkline Pharmaceuticals

Glaxosmithkline Pharmaceuticals

GLAXO

 ₹ 1,972.30
- ₹ 3.60
-0.18%
Alembic

Alembic

ALEMBICLTD

 ₹ 88.50
 ₹ 2.15
2.48%

Lupin Share Price

Lupin Limited is an Indian pharmaceutical company. The company manufactures, develops and markets a variety of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) worldwide. The company operates in the Cardiovascular, Diabetes, Asthma, Pediatric, CNS, Gastrointestinal, Anti-Infective and Non-Steroidal Anti-Inflammatory drug therapeutic segments and operates in the Anti-Tuberculosis and Cephalosporin segments. The company and its subsidiaries have manufacturing facilities in India, the United States, Mexico and Brazil, and trading and other ancillary and related activities also extend to global markets. Its complex generic portfolio includes Filgrastim, Pegfilgrastim, Etanercept and Albuterol, among others. Its biosimilars include Lupifil (Filgrastim), Lupifil-P (Peg-Filgrastim), and Etanercept.

Lupin FAQs

How to Buy Lupin Share?

virtual
To purchase Lupin shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Lupin (ticker symbol: lupin) on the trading platform provided by your broker and purchase the shares.

What's Lupin share price today?

virtual
The stock price of Lupin as of 10 May 2024 is ₹1,608.55

What is the Market Cap of Lupin?

virtual
Market capitalisation represents the total market value of a company's outstanding shares. As of 10 May 2024, Lupin (ticker symbol: lupin) has a market capitalisation of approximately ₹3,43,61,71,09,360.00

What is the PE and PB ratio of Lupin?

virtual
Lupin Ltd's price-to-book ratio as of 10 May 2024 is 2.3563213, reflecting the market's valuation compared to its asset value. As of 10 May 2024, the trailing twelve months P/E (price-to-earnings) ratio is 0, indicating the market values the company at around ₹0.00 for every ₹1 of earnings

What is the 52 Week High and Low of Lupin Share?

virtual
Lupin Ltd (lupin) hit its 52-week high at ₹1,704.25, and its 52-week low at { ₹742.45}.

Want to learn and earn in Stocks?